Lay Summary Artificial intelligence (AI) systems designed to assist doctors in decisions regarding diagnoses, investigations, and treatment of patients, called generative AI clinical decision support tools (GenAI CDS), are rapidly entering medical practice. While such tools promise to improve care by identifying conditions doctors might otherwise miss, they raise difficult legal and ethical questions. When a GenAI CDS recommends a test that a physician declines to order, and the patient later develops a serious condition that earlier testing might have detected, who bears responsibility?
No takes yet. Share an insight, caveat, or question.
MacLeod et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: